サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564107

生検装置の世界市場

Biopsy Devices

出版日
ページ情報
英文 196 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
生検装置の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

生検装置の世界市場は2030年までに59億米ドルに達する見込み

2023年に43億米ドルと推定される生検装置の世界市場は、分析期間2023-2030年にCAGR 4.5%で成長し、2030年には59億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである超音波ガイド下生検は、CAGR 5.4％を記録し、分析期間終了までに24億米ドルに達すると予測されます。CT Scan-Guided Biopsy分野の成長率は、分析期間中CAGR 4.8%と推定されます。

米国市場は12億米ドルと推定、中国はCAGR 4.2％で成長予測

米国の生検装置市場は2023年に12億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR4.2％を引きずる形で、2030年までに9億2,470万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.5％と3.4％と予測されています。欧州では、ドイツがCAGR 3.7%で成長すると予測されています。

世界の生検装置市場- 主要動向と促進要因のまとめ

生検装置が注目される理由とは？

生検装置は、診断プロセス、特にさまざまながんの早期発見とモニタリングの要となっています。最近の生検装置の技術的進歩は、その精度、安全性、患者の快適性を著しく向上させています。伝統的な針生検から、先進的な画像誘導法やロボット支援法に至るまで、これらの機器の進化には目を見張るものがあります。これらの技術革新は、組織採取の精度を向上させただけでなく、処置の侵襲性を最小限に抑え、回復時間の短縮と合併症の減少につながっています。超音波、MRI、CTスキャンなどの画像技術と生検装置との統合は、この分野にさらなる革命をもたらし、手技中のリアルタイムのガイダンスを可能にし、採取されたサンプルが最も関連性の高い部位から採取されることを保証し、それによって診断精度を高めています。

エンドユーザー動向は生検装置市場をどのように形成していますか？

生検装置の利用は、ヘルスケア分野における最終用途動向の変化により、顕著な変化を見せています。がんやその他の慢性疾患の罹患率の上昇に伴い、早期かつ正確な診断ツールに対する需要が高まっています。病院や診断センターが生検装置の主要ユーザーですが、外来診療所やがん専門センターがこれらの技術を採用する傾向が強まっています。このシフトは、正確でタイムリーな診断を必要とする早期発見と個別化医療が重視されていることが主な原因です。さらに、世界人口の高齢化と定期的な健康診断に対する意識の高まりが、ルーチン生検の需要を押し上げています。この動向は、ヘルスケアのインフラが高度な診断法を支えている先進国で特に顕著であるが、新興国市場も急速に追いついており、こうした機器の需要をさらに促進しています。

生検装置の将来を形作るイノベーションとは？

生検装置の未来は、患者の転帰と診断精度の向上を目指した絶え間ないイノベーションによって形作られています。最も重要な開発の一つは、従来の組織生検に代わるより侵襲性の低いリキッドバイオプシーの登場です。リキッドバイオプシーは、血液サンプルから循環腫瘍細胞やDNAを分析するもので、手術をすることなく、がんの存在と進行に関する重要な情報を提供します。技術革新のもう一つの分野は、二次汚染や感染のリスクを低減する使い捨ての生検装置の開発です。これらの機器は、無菌性が最優先される環境では特に価値があります。さらに、ロボット支援生検手技の進歩は、サンプル採取の精度と一貫性を高め、人為的ミスを減らし、より複雑な手技をより簡単に行うことを可能にしています。これらの技術革新は、生検プロセスの効率を向上させるだけでなく、生検によって診断できる疾患の範囲を拡大しつつあります。

生検装置市場の成長の原動力は？

生検装置市場の成長は、いくつかの要因によってもたらされます。がんやその他の慢性疾患の有病率の上昇により、早期かつ正確な診断が急務となっており、これが市場成長の主な促進要因の1つとなっています。画像技術の統合やより低侵襲な生検技術の開発といった技術の進歩により、生検の精度と安全性が大幅に向上し、患者にとってより身近で受け入れやすいものとなっています。加えて、個別化医療の動向は、治療がますます個人の疾患特有の特徴に合わせて行われるようになり、精密な診断ツールに対する需要を煽っています。さらに、新興市場におけるヘルスケア・インフラの拡大は、先進的な生検装置の導入に新たな機会を生み出しています。がん研究や早期診断プログラムに対する政府の取り組みや資金援助も、市場の成長を支える重要な役割を果たしています。早期発見の重要性に対する認識が高まり続ける中、生検装置市場は、技術革新と世界のヘルスケア慣行のシフトの両方によって、持続的な需要が見込まれます。

調査対象企業の例（全46件）

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group, Inc.
  • FUJIFILM Holdings Corporation
  • Hologic, Inc.
  • Inrad, Inc.
  • Medtronic PLC
  • Olympus Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10731

Global Biopsy Devices Market to Reach US$5.9 Billion by 2030

The global market for Biopsy Devices estimated at US$4.3 Billion in the year 2023, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Ultrasound-Guided Biopsy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the CT Scan-Guided Biopsy segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 4.2% CAGR

The Biopsy Devices market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$924.7 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Biopsy Devices Market - Key Trends and Drivers Summarized

Why Are Biopsy Devices Gaining Attention?

Biopsy devices have become a cornerstone in the diagnostic process, particularly in the early detection and monitoring of various cancers. Recent technological advancements in biopsy devices have significantly improved their accuracy, safety, and patient comfort. From traditional needle biopsies to advanced image-guided and robotic-assisted techniques, the evolution of these devices is remarkable. These innovations have not only enhanced the precision of tissue sampling but also minimized the invasiveness of the procedure, leading to quicker recovery times and fewer complications. The integration of imaging technologies like ultrasound, MRI, and CT scans with biopsy devices has further revolutionized the field, enabling real-time guidance during the procedure and ensuring that the samples collected are from the most relevant areas, thereby increasing diagnostic accuracy.

How Are End-Use Trends Shaping the Biopsy Devices Market?

The utilization of biopsy devices is seeing a notable shift, driven by changes in end-use trends within the healthcare sector. With the rising incidence of cancer and other chronic diseases, there is an increasing demand for early and accurate diagnostic tools. Hospitals and diagnostic centers are the primary users of biopsy devices, but there’s a growing trend of outpatient clinics and specialized cancer centers adopting these technologies. This shift is largely due to the emphasis on early detection and personalized medicine, which requires precise and timely diagnosis. Moreover, the aging global population, coupled with the growing awareness of regular health check-ups, is driving the demand for routine biopsy procedures. This trend is particularly noticeable in developed regions, where healthcare infrastructure supports advanced diagnostic practices, but emerging markets are quickly catching up, further fueling the demand for these devices.

What Innovations Are Shaping the Future of Biopsy Devices?

The future of biopsy devices is being shaped by continuous innovations aimed at improving patient outcomes and diagnostic accuracy. One of the most significant developments is the advent of liquid biopsies, which offer a less invasive alternative to traditional tissue biopsies. Liquid biopsies analyze circulating tumor cells or DNA from a blood sample, providing crucial information about the presence and progression of cancer without the need for surgery. Another area of innovation is the development of single-use, disposable biopsy devices that reduce the risk of cross-contamination and infection. These devices are particularly valuable in settings where sterility is a top priority. Additionally, advancements in robotic-assisted biopsy procedures are enhancing the precision and consistency of sample collection, reducing human error, and enabling more complex procedures to be performed with greater ease. These innovations are not only improving the efficiency of the biopsy process but are also expanding the range of conditions that can be diagnosed through biopsy.

What’s Driving the Growth in the Biopsy Devices Market?

The growth in the biopsy devices market is driven by several factors. The rising prevalence of cancer and other chronic diseases has led to an urgent need for early and accurate diagnosis, which is one of the primary drivers of market growth. Technological advancements, such as the integration of imaging technologies and the development of less invasive biopsy techniques, have significantly improved the accuracy and safety of biopsies, making them more accessible and acceptable to patients. Additionally, the trend toward personalized medicine is fueling demand for precise diagnostic tools, as treatments are increasingly tailored to the specific characteristics of an individual’s disease. Moreover, the expansion of healthcare infrastructure in emerging markets is creating new opportunities for the adoption of advanced biopsy devices. Government initiatives and funding for cancer research and early diagnosis programs are also playing a crucial role in supporting market growth. As awareness of the importance of early detection continues to grow, the biopsy devices market is expected to experience sustained demand, driven by both technological innovations and shifts in healthcare practices globally.

Select Competitors (Total 46 Featured) -

  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group, Inc.
  • FUJIFILM Holdings Corporation
  • Hologic, Inc.
  • Inrad, Inc.
  • Medtronic PLC
  • Olympus Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Biopsy Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Imaging Technologies Propel Growth of Biopsy Devices Market
    • Rising Prevalence of Cancer Spurs Demand for Innovative Biopsy Solutions
    • Emerging Liquid Biopsy Techniques Expand Addressable Market Opportunity
    • Growing Preference for Minimally Invasive Procedures Strengthens Business Case for Biopsy Devices
    • Integration of AI and Machine Learning in Diagnostics Generates Demand for Enhanced Biopsy Devices
    • Aging Population and Increased Cancer Screening Programs Sustain Market Growth
    • Focus on Early Detection Solutions Propels Market Expansion
    • Innovations in Needle Design and Tissue Sampling Methods Drive Product Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biopsy Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ultrasound-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Ultrasound-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for CT Scan-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for CT Scan-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for CT Scan-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for MRI-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for MRI-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for MRI-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Steretactics-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Steretactics-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Steretactics-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Imaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Imaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Imaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostics Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biopsy Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Biopsy Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biopsy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Biopsy Devices by Imaging Technology - Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for Ultrasound-Guided Biopsy, CT Scan-Guided Biopsy, MRI-Guided Biopsy, Steretactics-Guided Biopsy and Other Imaging Technologies for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2014, 2024 & 2030

IV. COMPETITION